Seguir
Ilya Sukhanov
Ilya Sukhanov
First Pavlov State Medical Univercity of Saint Petersburg
Dirección de correo verificada de iit.it
Título
Citado por
Citado por
Año
Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats
D Leo, I Sukhanov, F Zoratto, P Illiano, L Caffino, F Sanna, G Messa, ...
Journal of Neuroscience 38 (8), 1959-1972, 2018
2062018
Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue-and schedule-induced reinstatement of nicotine self-administration behavior in rats
AY Bespalov, OA Dravolina, I Sukhanov, E Zakharova, E Blokhina, ...
Neuropharmacology 49, 167-178, 2005
1512005
TAAR1 modulates cortical glutamate NMDA receptor function
S Espinoza, G Lignani, L Caffino, S Maggi, I Sukhanov, D Leo, L Mus, ...
Neuropsychopharmacology 40 (9), 2217-2227, 2015
1382015
Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.
M Pietraszek, I Sukhanov, P Maciejak, J Szyndler, A Gravius, A Wisłowska, ...
European journal of pharmacology 514 (1), 25, 2005
1252005
Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1
S Espinoza, V Ghisi, M Emanuele, D Leo, I Sukhanov, TD Sotnikova, ...
Neuropharmacology 93, 308-313, 2015
1092015
Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases
MD Schwartz, JJ Canales, R Zucchi, S Espinoza, I Sukhanov, ...
Expert opinion on therapeutic targets 22 (6), 513-526, 2018
672018
Trace amine-associated receptor 5 provides olfactory input into limbic brain areas and modulates emotional behaviors and serotonin transmission
S Espinoza, I Sukhanov, EV Efimova, A Kozlova, KA Antonova, P Illiano, ...
Frontiers in molecular neuroscience 13, 18, 2020
612020
Increased context-dependent conditioning to amphetamine in mice lacking TAAR1
I Sukhanov, L Caffino, EV Efimova, S Espinoza, TD Sotnikova, L Cervo, ...
Pharmacological research 103, 206-214, 2016
482016
TAAR1-dependent effects of apomorphine in mice
I Sukhanov, S Espinoza, DS Yakovlev, MC Hoener, TD Sotnikova, ...
International Journal of Neuropsychopharmacology 17 (10), 1683-1693, 2014
472014
Trace amine-associated receptor 1 modulates the locomotor and sensitization effects of nicotine
I Sukhanov, M Dorofeikova, A Dolgorukova, A Dorotenko, RR Gainetdinov
Frontiers in pharmacology 9, 329, 2018
322018
Effects of NMDA receptor channel blockers, MK-801 and memantine, on locomotor activity and tolerance to delay of reward in Wistar− Kyoto and spontaneously hypertensive rats
IM Sukhanov, ES Zakharova, W Danysz, AY Bespalov
Behavioural pharmacology 15 (4), 263-271, 2004
322004
Activation of trace amine-associated receptor 1 attenuates schedule-induced polydipsia in rats
I Sukhanov, A Dorotenko, A Dolgorukova, MC Hoener, RR Gainetdinov, ...
Neuropharmacology 144, 184-192, 2019
152019
Novel translational rat models of dopamine transporter deficiency
D Leo, I Sukhanov, RR Gainetdinov
Neural Regeneration Research 13 (12), 2091-2093, 2018
152018
The action of TAAR1 agonist RO5263397 on executive functions in rats
A Dorotenko, M Tur, A Dolgorukova, N Bortnikov, IV Belozertseva, ...
Cellular and Molecular Neurobiology 40 (2), 215-228, 2020
142020
Unlocking the therapeutic potential of ulotaront as a trace amine-associated receptor 1 agonist for neuropsychiatric disorders
SR Kuvarzin, I Sukhanov, K Onokhin, K Zakharov, RR Gainetdinov
Biomedicines 11 (7), 1977, 2023
132023
Dopamine transporter deficient rodents: perspectives and limitations for neuroscience
A Savchenko, G Targa, Z Fesenko, D Leo, RR Gainetdinov, I Sukhanov
Biomolecules 13 (5), 806, 2023
122023
Discovery of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 2-(5-(4′-Chloro-[1,1′-biphenyl]-4-yl)-4H-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the …
M Krasavin, A Lukin, I Sukhanov, AS Gerasimov, S Kuvarzin, EV Efimova, ...
Biomolecules 12 (11), 1650, 2022
112022
Behavioral effects of a potential novel TAAR1 antagonist
VM Lam, CA Mielnik, C Baimel, P Beerepoot, S Espinoza, I Sukhanov, ...
Frontiers in pharmacology 9, 953, 2018
112018
Inhibition of PDE10A in a new rat model of severe dopamine depletion suggests new approach to non-dopamine Parkinson’s disease therapy
I Sukhanov, A Dorotenko, Z Fesenko, A Savchenko, EV Efimova, MS Mor, ...
Biomolecules 13 (1), 9, 2022
102022
The lack of dopamine transporter is associated with conditional associative learning impairments and striatal proteomic changes
A Savchenko, C Müller, J Lubec, D Leo, V Korz, L Afjehi-Sadat, ...
Frontiers in psychiatry 13, 799433, 2022
92022
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20